HIV drug shows potential to combat form of dystonia in preclinical study
In mouse-model research, HIV medication restored brain abnormalities in DYT1 dystonia.
Posts tagged as
David Vaillancourt
AI tool to be tested for improved Parkinson’s diagnosis
Researchers launch study to aid in quick and accurate early Parkinson’s diagnosis versus two related but distinct disorders.
Doctoral student training program in movement disorders research receives renewal
The program trains doctoral students to become independent researchers in Parkinson’s disease, dystonia, tremor and ataxia.
Noninvasive, automated MRI for Parkinson’s diagnosis
Dr. David Vaillancourt leads international study demonstrating that a non-invasive, automated MRI method can pinpoint various types of Parkinson’s disease and Parkinson’s-like syndromes.
Movement disorders training program hosts NINDS leadership
National Institute of Neurological Disorders and Stroke leadership recently visited with Predoctoral Interdisciplinary Training in Movement Disorders and Neurorestoration program participants.
Two Jocks, One Goal: Cure Parkinson’s
In the laboratory of David Vaillancourt, Ph.D., researchers are applying a groundbreaking, noninvasive imaging biomarker they identified to discover better diagnostics and treatment of Parkinson's disease.
Parkinson’s effect on the primary motor cortex examined
A review by Dr. David Vaillancourt, a member of the MBI's executive committee, was recently featured on the cover of the journal Movement Disorders.
